Jubilant Pharmova Limited
NSE:JUBLPHARMA.NS
Overview | Financials
Company Name | Jubilant Pharmova Limited |
Symbol | JUBLPHARMA.NS |
Currency | INR |
Price | 1,224.2 |
Market Cap | 194,991,800,200 |
Dividend Yield | 0.7% |
52-week-range | 318.75 - 1,247.15 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Arvind Chokhany |
Website | https://www.jubilantpharmova.com |
An error occurred while fetching data.
About Jubilant Pharmova Limited
Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Pharmaceuticals; Contract Research & Development Services; and Proprietary Novel Drugs. The Pharmaceuticals segment engages in the manufacturing and supply of allergy therapy products, contract manufacturing of sterile injectables and non-sterile products, active pharmaceutical ingredients, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD